E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.
Elliott M. Antman,Jeroen J. Bax,Richard A. Chazal,Mark A. Creager,Gerasimos Filippatos,Jonathan L. Halperin,Steven R. Houser,JoAnn Lindenfeld,Fausto J. Pinto,Panos Vardas,Mary Norine Walsh,Kim A. Williams,José Luis Zamorano +12 more
TL;DR: The ESC 2016 Guideline on the Diagnosis of heart failure as mentioned in this paper has been published in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), and the European Society ofCardiology (ESC).
Journal ArticleDOI
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes
Shaheeda Ahmed,Christopher P. Cannon,Christopher P. Cannon,Robert P. Giugliano,Robert P. Giugliano,Sabina A. Murphy,Sabina A. Murphy,David A. Morrow,David A. Morrow,Elliott M. Antman,Elliott M. Antman,Eugene Braunwald,Eugene Braunwald,C. Michael Gibson,C. Michael Gibson +14 more
TL;DR: The combination of RI and DM was associated with a particularly high risk of MI and death/MI suggesting that attention to preserving renal function may be of particular benefit for reducing cardiovascular risk in diabetic patients.
Journal ArticleDOI
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial
Ramón Corbalán,Jose C. Nicolau,Jose Lopez-Sendon,Armando Garcia-Castillo,Rodrigo Botero,Gustavo Sotomora,Manuel Horna,Christian T. Ruff,Rose A. Hamershock,Laura T. Grip,Elliott M. Antman,Eugene Braunwald,Robert P. Giugliano +12 more
TL;DR: After multivariable adjustment, LatAm subjects with atrial fibrillation had higher rates of intracranial hemorrhage and death than nLAS, and outcomes with higher-dose edoxaban versus warfarin were at least as favorable in Lat am subjects as in nLas, with an even greater reduction in hemorrhagic stroke seen in LatAm.
Journal ArticleDOI
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial
Chadwick D. Miller,Anindita Banerjee,Kenneth W. Mahaffey,Michael C. Kontos,Gregory J. Fermann,Charles V. Pollack,Elliott M. Antman,Philip E. Aylward,Shaun G. Goodman,Renato M. Santos,James J. Ferguson,Robert M. Califf,James W. Hoekstra +12 more
TL;DR: Patients with EMI had lower rates of death or re-infarction at 30 days compared with patients presenting with positive troponin results and initial treatment patterns were similar among patients with E MI and MI in the SYNERGY trial.